Introduction {#Sec1}
============

Ciliopathies comprise a group of disorders associated with genetic mutations encoding defective proteins, which result in abnormal formation or function of cilia. As cilia are a component of almost all cells, ciliary dysfunction can manifest as a constellation of features that include primarily retinal degeneration, renal disease and cerebral anomalies. The notion of a "ciliopathic" disorder was first attributed to Bardet--Biedl syndrome (BBS), when Ansley and colleagues identified genetic mutations in BBS8 whereby the encoded protein was noted to have a *pilF* domain, suggesting a conserved role for BBS8 in prokaryotic pilus formation \[[@CR1]\]. Intriguingly, the phenotypic consequences in one family with a homozygous null mutation in *BBS8* included situs inversus, a known defect of the embryonic nodal cilium \[[@CR1]\]. Subsequent immunohistochemical analysis confirmed the localisation of BBS8 to centrosomes and basal bodies within human embryonic kidney cells (HEK293) in addition to spermatids, the connecting cilium of the retina and the ciliated columnar epithelial cells of the lung \[[@CR1]\]. Further supporting evidence for a role in cilia function came from the elegant demonstration that other BBS orthologues in *Caenorhabditis elegans*, *bbs1*, *bbs2* and *bbs7*, all localised to the nematode ciliated sensory neurons where osm-5, the orthologue of the mouse polycystic kidney disease gene, *polaris*, was also previously localised. Thereafter, the innovative utilisation of comparative genomic studies whereby the proteome of the non-flagellated organism, *Arabidopsis*, was subtracted from the shared proteome of the ciliated/flagellated organisms, *Chlamydomonas* and human, led to the discovery of mutations in another gene, *BBS5*, in patients with BBS \[[@CR2]\]. Following development of the original ciliary proteome database, subsequent integration of ciliary proteomes from a range of different organisms have contributed to the current ciliary proteome database (<http://www.ciliaproteome.org>) \[[@CR3]\]. The ciliary proteome database was employed by Beales and colleagues to identify mutations in *IFT80*, which encodes an intraflagellar transport protein in a subset of patients with Jeune asphyxiating thoracic dystrophy (JATD), following the observation that patients with JATD exhibited typical ciliopathy features of retinal degeneration, renal disease and skeletal dysplasia \[[@CR4]\].

In the ensuing text, we will provide an overview of the structure and function of cilia, which will provide a basis for the subsequent clinical description of a range of ciliopathic disorders. We will also highlight how ciliopathies can be phenotypically heterogeneous from variation at a single locus while mutations affecting a number of different loci can at the same time result in similar phenotypes. Thereafter, a brief description will follow on the role of ciliary dysfunction in certain phenotypic features that include renal abnormalities, liver disease, retinal degeneration and skeletal dysplasias.

Overview of ciliary biology {#Sec2}
===========================

As many as 1,000 different polypeptides are recognised within the current ciliary proteome, highlighting the structural complexity of this highly conserved organelle. Projecting from the cell surface, cilia are microtubule-based, hair-like cytoplasmic extensions with motile and a range of sensory functions, which are critical for developmental and physiological functions \[[@CR5]\]. Comprising the microtubular backbone, the ciliary axoneme develops from and is anchored to a specialised centriole called the basal body, which acts as a microtubule organising centre (MTOC) for its ciliary counterpart (Fig. [1](#Fig1){ref-type="fig"}). The ciliary axoneme consists of nine doublet microtubules that originate at the triplet microtubules of the basal body centriole and extend the length of the cilium. Cilia fall into two broad categories: motile and immotile. Primary cilia are typically immotile and consist of nine peripheral doublet microtubules, while motile cilia in addition contain a central pair of singlet microtubules ("9 + 2" arrangement) to which they are connected by the radial spoke proteins (Fig. [1](#Fig1){ref-type="fig"}c). Immotile cilia are characterised by the absence of the central pair of singlet microtubules ("9 + 0" arrangement; Fig. [1](#Fig1){ref-type="fig"}c) \[[@CR6]\]. Motile cilia are distinguished from primary cilia by their ability to beat rhythmically, an activity that is powered by adenosine triphosphate (ATP), hydrolysed by dynein proteins, which are anchored to the inner and outer aspects of peripheral doublet microtubules \[[@CR7]\]. Motile cilia are utilised in both unicellular and multicellular organisms for locomotion. Defective motile cilia can result in primary ciliary dyskinesias, which comprise a heterogeneous group of disorders characterised by bronchiecstasis, left--right asymmetry and infertility. Primary cilia have chemosensory, osmosensory and phototransduction functions, and will be discussed in more detail later in this review. Fig. 1The primary cilium. **a**, **b** Cilia are cytoplasmic extensions projecting from the cell surface and composed of a microtubular-based ciliary axoneme. The transition zone is where the microtubules are reorganised into pairs and anchor the pairs to the membrane. Within this region, proteins involved in trafficking along the axoneme also accumulate. **b**, **c** Schematic of a transverse section through**c** the motile cilium, showing the radial spoke proteins and outer dynein arms, and **d** the non-motile cilium

Ciliary assembly {#Sec3}
================

Cilia arise from basal bodies, which are formed from centrioles, complex microtubule-based structures located within the cytoplasm (Fig. [1](#Fig1){ref-type="fig"}b) \[[@CR8]\]. Acting as an intracellular scaffold, the microtubules at the pericentriolar material (PCM) direct the trafficking of vesicles and organelles. Delivery of ciliary cargo occurs in a sequential manner, which involves sorting and packaging into carrier vesicles, docking and fusion of vesicles with the base of the cilium and assembly of cilia from the ciliary base to the tip (Fig. [2](#Fig2){ref-type="fig"}). Ciliary targeting and assembly is mediated by several multiprotein complexes that include intraflagellar transport (IFT) proteins and the BBSome, a stable complex of at least eight BBS proteins (BBS 1, 2, 4, 5, 7, 8, 9 and BBIP10), which are modulated by members of the Arf and Rab family of proteins \[[@CR9]\]. From the ciliary base, cilia are assembled by IFT, which utilises two microtubule-associated motor proteins called kinesins and dyneins. Structural axonemal components and membrane receptors are transported in an anterograde manner along the ciliary axoneme by kinesin-II. Retrograde transport of recycled proteins down along the axoneme towards the basal body is undertaken by the cytoplasmic dynein motor proteins \[[@CR10]\]. Kinesin-II is a heterotrimeric complex comprised of two motor subunits known as KIF3A and KIF3B in addition to a non-motor subunit known as kinesin-associated protein (KAP). IFT particles are composed of two protein complexes, IFTA with 6 protein subunits and IFTB with 13 protein subunits (Fig. [3](#Fig3){ref-type="fig"}) \[[@CR11]\]. Disruption of either the IFT motors or the basal body proteins essential for their function leads to impaired cilia assembly \[[@CR12], [@CR13]\]. Fig. 2Intraflagellar transport. Elongation of the axoneme at the distal tip relies on intraflagellar transport (IFT). Anterograde IFT is mediated by kinesin II motors along with axonemal precursors, while retrograde IFT is mediated by a dynein motor. IFT Type A complexes are linked to retrograde transport and IFT Type B complexes are linked to anterograde transportFig. 3The BBSome and vesicular trafficking to the primary cilium. The BBSome is a multi-protein complex comprising BBS proteins (BBS 1, 2, 4, 5, 7, 8 and 9) that localises predominantly at the ciliary base and mediates vesicular transport to the cilium

Signal transduction at the cilium {#Sec4}
=================================

Hedgehog signalling {#Sec5}
-------------------

The Hedgehog signalling pathway is a highly conserved and ubiquitous signalling pathway that plays a key role in several developmental contexts regulating a variety of cellular processes that include both cell fate specification and cell proliferation. Hedgehog (Hh) ligands include Sonic hedgehog (Shh) and Indian hedgehog (Ihh), which bind to Patched (Ptch), a transmembrane receptor that represses activation of a G-protein coupled receptor, Smoothened (Smo) \[[@CR14]\]. On ligand binding, Smo, moves in a lateral transport pathway from the plasma membrane and accumulates at the ciliary membrane \[[@CR15]\]. Activated Smo increases the accumulation of Gli2, a transcription factor at the ciliary tip, which then translocates to the nucleus where it activates Hh target gene expression. In the presence of Hh ligand, Smo interacts within a molecular complex consisting of IFT machinery, Fused (Fu) and Suppressor of Fused (SuFu). Mutations in genes encoding *Ift172* and *Ift88* were identified in two mouse mutants that showed characteristic defects in Shh signalling following an ethylnitrosourea (ENU) mutagenesis screen undertaken for embryonic patterning mutations. Genetic studies showed that IFT proteins act at the heart of the Shh pathway, downstream of Ptch1 and Smo and upstream of the Gli transcription factors, where they mediate the production of activated to repressor forms of Gli, thereby regulating Hh pathway activity \[[@CR16]\].

Wnt signalling {#Sec6}
--------------

Several studies have implicated ciliary and basal body proteins in the regulation of Wnt signalling \[[@CR17], [@CR18]\]. The Wnt family encodes a family of 19 secreted glycoproteins that regulate a variety of biological processes implicated in development and disease. Ligand binding to a complex of the Frizzled (Fz) receptor and the low-density lipoprotein receptors, LRP5 or LRP6, initiates signalling through Dishevelled (Dvl). Inversin (Inv) interacts with Dvl and targets the cytoplasmic fraction of Dvl for degradation \[[@CR19]\]. In the absence of Wnt stimuli, β-catenin is constitutively phosphorylated by the β-catenin destruction complex consisting of axin, adenomatous polyposis coli (APC) and glycogen synthase kinase 3β \[GSK3β\]. Phosphorylated β-catenin is targeted for degradation. In canonical Wnt signalling, the ligand binds to a complex of the Fz receptor and LRP5/6 co-receptor, which then binds to Axin and Dvl, leading to stabilisation of β-catenin in the cytoplasm. β-catenin migrates into the nucleus, replaces TLE, and activates transcription of β-catenin/TCF/LEF1-responsive genes. In non-canonical signalling, activated Dvl is targeted to the membrane and activates downstream targets. Disruption of ciliary or basal body components leads to loss of non-canonical Wnt signalling and stabilisation of both Dvl and β-catenin in the cytoplasm and nucleus, resulting in activation of canonical Wnt signalling.

Emerging evidence suggests that non-canonical Wnt signalling, also known as planar cell polarity signalling (PCP), plays a role in ciliary formation. Mice mutant for the core PCP effector, Fuzzy, have neural tube defects, skeletal dysmorphologies and Hedgehog signalling defects stemming from disrupted ciliogenesis. Further studies demonstrated the key role of Fuz in trafficking ciliary cargo to basal bodies and to the ciliary apex while interaction with a Rab-small GTPase is required for ciliogenesis.

Diseases associated with ciliary dysfunction {#Sec7}
============================================

As cilia are a component of almost all vertebrate cells, ciliary dysfunction can manifest as a constellation of features that include primarily retinal degeneration, renal disease and cerebral anomalies. Additional manifestations include congenital fibrocystic diseases of the liver and pancreas, diabetes, obesity and skeletal dysplasias. Phenotypically heterogeneous, ciliopathic features can manifest from variation at a single locus while mutations affecting a number of different loci can, at the same time, result in similar phenotypes. Mutations in over 40 genes to date have been associated with ciliopathic features (Tables [1](#Tab1){ref-type="table"}, [2](#Tab2){ref-type="table"}). However, with over 1,000 polypeptides currently identified within the ciliary proteome, several other disorders associated with this constellation of clinical signs will likely be ascribed to mutations in other ciliary genes. A brief description of the characteristic features of some of the ciliopathies encountered by paediatric nephrologists is outlined in the following section. Table 1Phenotypic overlap in the ciliopathies. (Table modified from Gerdes et al. \[[@CR130]\], used with permission)PhenotypeLCASLSNPHPMKSBBSJBTSCerebellar√√√hypoplasiaEncephalocele√Hepatic disease√√√√√Renal disease√√√√√Mental retardation√√√√Obesity√√Polydactyly√√√Retinopathy√√√√√Situs inversus√√√√√Skeletal dysplasia√Cleft palate√LCA, Leber's congenital amaurosis; NPHP, nephronophthisis; BBS, Bardet--Biedl syndrome; SLS, Senior--Løken syndrome; JBS, Joubert syndrome; MKS, Meckel--Gruber syndromeTable 2Genotypic overlap in the ciliopathies. (Table modified from Gerdes et al. \[[@CR130]\], used with permission)GeneLCASLSNPHPMKSBBSJBTSOFD*CEP290*√√√√√√*NPHP1*√√√*INVS*√√*NPHP3*√√√*NPHP4*√√*NPHP5*√√*GLIS2*√*NEK8*√*AHI1*√*TMEM67*√√√√*RPGRIPL1*√√√√*ARL13B*√*BBS1*√*BBS2*√√*BBS3*√*BBS4*√√*BBS5*√*BBS6*√√*BBS7*√*BBS8*√*BBS9*√*BBS10*√*BBS11*√*BBS12*√*MGC1203*√*MKS1*√√*BBS15*√*CC2D2A*√√*TMEM216*√√√*INPP5E*√*XNPEP3*√*OFD1*^a^√√LCA, Leber's congenital amaurosis; NPHP, nephronophthisis; BBS, Bardet--Biedl syndrome; SLS, Senior--Løken syndrome; JBS, Joubert syndrome, MKS, Meckel--Gruber syndrome, OMA, oculomotor apraxia, OFD, orofaciodigital syndrome^a^If in males

Joubert syndrome and related disorders {#Sec8}
--------------------------------------

Joubert syndrome (JBTS; MIM ID\# 213300) is a rare syndrome that is characterised by hypotonia, ataxia, psychomotor delay, irregular breathing pattern and oculomotor apraxia. Distinctive cerebellar and brain stem malformations associated with JBTS include vermis hypoplasia or agenesis (e.g. abnormalities at the pontomesencephalic junction). The characteristic "molar tooth sign" (MTS) on cranial magnetic resonance imaging (MRI) is demonstrated by elongated but thin superior cerebellar peduncles and mild vermis hypoplasia with the resulting images reminiscent of a section through a molar tooth and is characteristic of JBTS (Fig. [4](#Fig4){ref-type="fig"}d). Dandy--Walker malformations may be evident in approximately 10% of cases as a result of abnormal cerebrospinal fluid collections in the posterior fossa. Additional clinical features include retinal degeneration, cystic kidney disease (cystic dysplasia and nephronophthisis \[NPHP\]), ocular colobomas, occipital encephalocele, hepatic fibrosis, polydactyly, oral hamartomas and endocrine abnormalities. Fig. 4Clinical features of ciliopathies. **a** Renal ultrasound demonstrating multiple cysts distributed within the renal parenchyma (*white arrow*). **b** Renal biopsy demonstrating cystic tubular dilation and interstitial fibrosis characteristic of nephronophthisis (NPHP; *black arrow*). **c** Funduscopy of a patient with Bardet--Biedl syndrome demonstrating peripheral pigmentary changes in the retina. **d** Cranial MRI of a patient with Joubert syndrome demonstrating characteristic "molar tooth" sign (*white arrow*) as a result of cerebellar vermis hypoplasia

Genetically heterogeneous, JBTS has been associated with mutations in several genes, including INPP5E \[[@CR20]\], ARL13B \[[@CR21]\], CC2D2A \[[@CR22]\], RPGRIP1L \[[@CR23]\], TMEM67 \[[@CR24]\], NPHP1 \[[@CR25]\], AHI1 \[[@CR26]\], CEP290 \[[@CR27]\], CXORF5 \[[@CR28]\] and TMEM216 \[[@CR29]\]. Mutations in CEP290, a gene encoding a centrosomal protein with a molecular weight of 290 kDa, are responsible for about 50% of JBTS subgroup of ciliopathies, while they are rarely detected in other related (JSRD) phenotypes that include Leber's congenital amaurosis (LCA), Senior--Løken syndrome (SLS), nephronophthisis (NPHP), Meckel--Gruber syndrome (MKS), Bardet--Biedl syndrome (BBS) and orofaciodigital (OFD) syndrome \[[@CR30]\]. The majority of CEP290 mutations described to date are nonsense, splice-site or frameshift mutations resulting in loss of protein function. Part of the phenotypic heterogeneity associated with CEP290 mutations may be attributed to the number of proteins that CEP290 interacts with \[[@CR31]\]. For example, CEP290 exists in a complex with other proteins such as retinitis pigmentosa GTPase regulator, nephrocystin-4 and nephrocystin-8 \[[@CR32]\]. Hypomorphic mutations in NPHP6 and NPHP8 (also known as RPGRIP1-L), which are associated with relatively early-onset photoreceptor degeneration, disrupt their association with the retinitis pigmentosa GTPase regulator protein \[[@CR32]--[@CR34]\]. In a similar fashion, other mutated gene products, such as AHI1, which encodes jouberin, has been shown to interact with nephrocystin-1 \[[@CR35]\]. For a comprehensive review of the phenotypic and genotypic features associated with CEP290 mutations, the reader is referred to a recent excellent review on this topic \[[@CR31]\].

Meckel--Gruber syndrome (MKS, MIM ID \#249000) phenotypically overlaps with JBTS. Clinical features include occipital encephalocele and other posterior fossa defects, cystic dysplastic kidneys, hepatic bile duct proliferation and polydactyly. MKS is caused by mutations in several genes including MKS1 \[[@CR36]\], MKS3 (TMEM67) \[[@CR37]\], CEP290 \[[@CR24]\], RPGRIP1L \[[@CR23]\], CC2D2A \[[@CR38]\] and TMEM216 \[[@CR29]\]. Both JSRD and MKS are allelic at several loci (CEP290, TMEM216, TMEM67, RPGRIPL1, CC2D2A) \[[@CR23], [@CR24], [@CR29], [@CR39], [@CR40]\]. For example, homozygous missense mutations have recently been described in TMEM216, a tetraspan transmembrane protein required for ciliogenesis in patients with JSRD \[[@CR29]\]. Frameshift mutations in TMEM216, resulting in a truncated protein, were found in two Palestinian families with MKS in the same study, emphasising that MKS is thought to represent the severe end of the JSRD clinical spectrum.

Senior--Løken syndrome (SLS, MIM ID \#266900) is another rare disorder that shares phenotypic and genotypic overlap with JBTS and other ciliopathies including BBS and NPHP (Table [1](#Tab1){ref-type="table"}). The main clinical features are retinitis pigmentosa (RP) and renal disease. Presentation may occur in infancy or late childhood. RP may present either as congenital retinal blindness caused by retinal hypoplasia or as progressive retinal degeneration later in childhood with a classical fundoscopic appearance of tapetoretinal degeneration. The characteristic renal manifestation is that of nephronophthisis characterised by cystic dilatation of the renal tubules. However, both cystic renal dysplasia and polycystic kidneys have also been observed in SLS. Mutations have been identified in the following genes, which include CEP290 (also known as NPHP6 and MKS4) \[[@CR27]\], NPHP1 \[[@CR41]\], NPHP3 \[[@CR42]\], NPHP4 \[[@CR43]\] and NPHP5 (also known as IQCB1) \[[@CR44]\]. Significant genetic overlap is evident between SLS and JBTS (Table [2](#Tab2){ref-type="table"}).

Orofaciodigital syndrome {#Sec9}
------------------------

Orofaciodigital syndrome type 1 (OFDI; MIM 311200) is a rare X-linked dominant disorder whereby affected males die in utero. Characteristic features include malformation of the oral cavity, face and digits, in addition to central nervous system (CNS) abnormalities and cystic kidney disease \[[@CR45]\]. Mutations in OFD1, which encodes a centrosomal protein localised at the basal bodies at the origin of primary cilia has been described in OFD1 patients \[[@CR46]\]. Diminished ciliogenesis has been observed with disease-associated mutations and recent studies suggest that Ofd1 acts at the distal centriole to build distal appendages, recruit IFT proteins and thereafter stabilise centriolar microtubules at a defined length \[[@CR47]\]. *Ofd1*^*-/-*^ embryos display left--right patterning defects as a result of absent nodal cilia \[[@CR48]\]. A recent study has highlighted genetic overlap between OFD and JBTS, whereby OFD1 was found to be mutated in males with Joubert syndrome \[[@CR28]\].

Leber's congenital amaurosis {#Sec10}
----------------------------

Leber's congenital amaurosis (LCA, MIM ID \#204000) is a severe retinal dystrophy, which presents within the first year of life. Frequently, visual function is poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, hyperopia and keratoconus. Functionally, visual acuity is rarely better than 20/400 and the electroretinogram (ERG) is characteristically "non-detectable" or severely subnormal. A characteristic finding is Franceschetti's oculo-digital sign, comprising eye poking, pressing and rubbing. Genes implicated in LCA include GUCY2D \[[@CR49]\], RPE65 \[[@CR50]\], SPATA7 \[[@CR51]\], AIPL1 \[[@CR52]\], LCA5 \[[@CR53]\], RPGRIPL1 \[[@CR54]\], CRX \[[@CR55]\], CRB1 \[[@CR56]\], IMPD1 \[[@CR57]\], RD3 \[[@CR58]\], CEP290 \[[@CR27]\], NPHP5 \[[@CR44]\] and RDH12 \[[@CR59]\]. The ophthalmological manifestations of LCA may present as a manifestation of JSRD or SLS. Mutations in many of the same genes are responsible for these three overlapping phenotypes (Table [2](#Tab2){ref-type="table"}).

Bardet--Biedl syndrome {#Sec11}
----------------------

Primary features of Bardet--Biedl syndrome (BBS, MIM\# 209900) include rod-cone dystrophy, polydactyly, obesity, learning disabilities, hypogonadism and renal anomalies (Fig. [4](#Fig4){ref-type="fig"}). Renal malformations and abnormal renal function leading to end-stage renal disease (ESRD) can be a major cause of morbidity and are present in at least 40% of cases \[[@CR60]\]. Renal manifestations include renal dysplasia, cystic tubular disease (e.g. nephronophthisis) and less frequently, focal segmental glomerulosclerosis \[[@CR61], [@CR62]\]. Lower urinary tract malformations such as detrusor instability of the bladder occur, but are less common than upper tract malformations \[[@CR62]\]. Secondary features include speech delay or disorder, developmental delay, behavioural abnormalities, strabismus/cataracts/astigmatism, brachydactyly/syndactyly, ataxia/poor coordination/imbalance, mild hypertonia, anosmia, diabetes, fibrocystic liver disease, Hirschsprung's disease, and dental and cardiovascular anomalies \[[@CR62]\]. Craniofacial defects such as brachycephaly, macrocephaly, bitemporal narrowing, male frontal balding, large ears, short and narrow palpebral fissures, a long shallow philtrum, nasal anomalies, midfacial hypoplasia and mild retrognathia have been described in BBS \[[@CR63]\].

Sixteen genes are known to be associated with BBS (Table [2](#Tab2){ref-type="table"}): BBS1 \[[@CR64]\], BBS2 \[[@CR65]\], ARL6/BBS3 \[[@CR66]\], BBS4 \[[@CR67]\], BBS5 \[[@CR2]\], MKKS/BBS6 \[[@CR68]\], BBS7 \[[@CR69]\], TTC8/BBS8 \[[@CR1], [@CR70]\], B1/BBS9 \[[@CR70]\], BBS10 \[[@CR71]\], TRIM32/BBS11 \[[@CR72]\], BBS12 \[[@CR73]\], MKS1/BBS13 \[[@CR74]\], CEP290/BBS14 \[[@CR74]\] C2ORF86/FRITZ/BBS15 \[[@CR75]\] and SDCCAG8/BBS16 \[[@CR76]\]. The recent identification of mutations in MKS1 in BBS has supported the observation that MKS may represent a severe BBS phenotype \[[@CR74]\]. Furthermore, previous studies have shown that the BBS phenotype can vary considerably within affected families. Some of this intrafamilial variability can be accounted for by the presence of mutations at more than one BBS locus as well as the presence of additional modifying genes that exert an epistatic effect on known BBS loci. For example, heterozygous mutations in*MGC1203*, which encodes a pericentriolar protein that interacts with BBS proteins, have been described in BBS patients \[[@CR77]\]. As BBS proteins have now been shown to exist in a macromolecular complex, it is likely that mutant proteins within this complex can affect the function of interacting proteins existing within the same complex. Approximately 20% of persons with BBS do not have identifiable mutations in any of the 16 known BBS-related genes; therefore, it is possible that more BBS genes are yet to be identified.

McKusick--Kaufman syndrome (MKKS, MIM\#236700) is an autosomal recessive (AR) condition characterised by the triad of hydrometrocolpos (HMC), post-axial polydactyly (PAP) and congenital heart disease (CHD). Many cases of BBS have been misdiagnosed as MKKS in infancy or early childhood prior to the development of other manifestations of BBS. MKKS is caused by mutations in the *MKKS* gene, which can also cause BBS \[[@CR68]\].

Alström syndrome {#Sec12}
----------------

Alström syndrome (ALS, MIM\#203800) is an AR disorder characterised by cone-rod dystrophy, obesity, progressive sensorineural hearing impairment, dilated cardiomyopathy, the insulin resistance syndrome and developmental delay. Over 60% of individuals with Alström syndrome develop cardiac failure as a result of dilated cardiomyopathy at some stage of their lives. Males may have hypogonadotrophic hypogonadism. Renal disease may present as polyuria and polydipsia resulting from a urinary concentrating defect. End-stage renal disease (ESRD) can occur as early as the late teens. In contrast to BBS, Alström syndrome is characterised by relative preservation of cognitive function and the absence of polydactyly. Alström syndrome is caused by mutations in the gene*ALMS1* and alms1 localises specifically to the proximal ends of centrioles and basal bodies \[[@CR78], [@CR79]\].

Jeune asphyxiating thoracic dystrophy {#Sec13}
-------------------------------------

Jeune asphyxiating thoracic dystrophy (JATD; MIM\#208500) is a rare AR chondrodysplasia that is frequently associated with infantile death as a result of a severely constricted thoracic cage associated with respiratory insufficiency from pulmonary hypoplasia. Characteristic skeletal findings include a narrow thorax with short ribs, hypoplastic iliac wings, trident acetabular roofs (horizontal acetabular roofs with spur-like projections at the lower margins of the sciatic notches), and rhizomelic limb shortening (Fig. [5](#Fig5){ref-type="fig"}). Radiological confirmation of the diagnosis is essential \[[@CR80]\]. JATD is characterised by the presence of radiologically irregular metaphyseal ends, histopathologically hyperplastic proliferating chondrocytes and defective endochondral mineralisation. Other skeletal manifestations include post-axial polydactyly, brachydactyly and hydrocephalus \[[@CR81]\]. Both RP and retinal aplasia have been noted in JATD \[[@CR82]\]. Glomerulosclerosis and cystic renal disease, including NPHP, has been reported in JATD. Fibrocystic disease of both the liver and pancreas has been described \[[@CR83]\]. Early death usually occurs in the majority of patients as a consequence of asphyxia with or without pneumonia. Fig. 5Skeletal manifestations of ciliopathies. **a** A Jeune asphyxiating thoracic dystrophy (JATD) patient with a narrow thorax. **b** CT of same patient demonstrating short ribs and narrow thoracic cage. **c** Upper limb radiography of a patient with Mainzer--Saldino syndrome demonstrating acromesomelic shortening with irregular metaphyses and cone-shaped epiphyses

Jeune asphyxiating thoracic dystrophy is a genetically heterogeneous disorder. Beales and colleagues identified two missense mutations and an in-frame deletion in*IFT80*, the gene encoding the Ift80 protein, thereby linking JATD to ciliary dysfunction \[[@CR4]\]. Ift80 was shown to localise to the basal body of cilia in a murine chondrocytic cell line. Aberrant Shh signalling appears to underlie the skeletal manifestations observed in IFT mutants \[[@CR84]\]. Zebrafish morphant for *ift80* demonstrate downregulation of *ptc1*, a Shh binding receptor. Phenotypic similarity is observed in Ihh null mice compared with patients with JATD, in that they exhibit extremely short narrow rib cages. Similarly, mice carrying a mutation in *Pthrp*, a gene regulated by Ihh via Gli3 during chondrocyte differentiation also have short ribs and sternum leading to a narrow rib cage.

Ellis van Creveld syndrome {#Sec14}
--------------------------

Ellis van Creveld (EvC, MIM 225500) syndrome is a rare chondroectodermal dysplasia that falls under the differential diagnosis of JATD and is characterised by short limbs, short ribs, post-axial polydactyly and dysplastic nails and teeth \[[@CR85]\]. Nail dysplasia and a peculiar upper lip distinguish EvC from Jeune syndrome, while congenital heart disease such as atrial septal defects occur in about 60% of affected individuals and are rare in JATD. Mutations in*EVC1* have been described in Amish and Brazilian pedigrees of EvC, but only accounted for a small proportion of affected cases, thereby suggesting that EvC is a heterogeneous disease \[[@CR86]\]. More recently, mutations in a second gene,*EVC2*, have been described in an Ashkenazi child with EvC \[[@CR87]\]. The Evc protein was shown to localise to the base of the primary cilium of chondrocytes and defective Ihh signalling was observed in proliferating chondrocytes of Evc-null mice \[[@CR88]\].

Sensenbrenner syndrome {#Sec15}
----------------------

Sensenbrenner syndrome (also known as cranioectodermal dysplasia, MIM \#218330), a recessive disorder similar to EvC, but with the addition of renal cysts and dolichocephaly (with sagittal suture synostosis) and sparse, slow-growing, fine hair, epicanthal folds, hypodontia and/or microdontia, brachydactyly and a narrow thorax. Mutations in two IFT genes,*IFT122* and*WDR35*, have been implicated in CED with*WDR35* recently identified by exome sequencing \[[@CR89], [@CR90]\]. As both gene products encode for ciliary proteins, Sensenbrenner syndrome has recently been classified as a ciliopathic disorder.

Jeune asphyxiating thoracic dystrophy has been described in patients with JBTS and intriguingly, no mutation has been identified in any of the known causative genes for either syndrome. Therefore, for such patients it is highly likely that further cases of JATD will be attributed to ciliary dysfunction in the future.

Systemic manifestations of the ciliopathies {#Sec16}
===========================================

While disease manifestation in any organ can occur in the context of ciliopathic dysfunction, the predominant organs affected include the kidney, eye, liver and brain. In the ensuing text, we will outline the range of diseases that can occur as each of these organs in the context of ciliary dysfunction. Within each organ, diseases can be developmental phenotypes presenting at birth or later in childhood. Often this may depend on the severity of the underlying mutation in addition to the number of defective proteins encoded where more than one mutation in a ciliary gene occurs.

Ciliary dysfunction and renal disease {#Sec17}
-------------------------------------

A spectrum of renal diseases has been described as a feature of several ciliopathic syndromes and includes a morphologically heterogeneous group of disorders that have been classified as polycystic, renal medullary cystic disease and cystic renal dysplasia. We will briefly outline the clinical and morphological features that distinguish each of these renal phenotypes. A brief description will follow outlining the underlying genetic aetiology, lessons learned from animal models of cystic kidney disease and the role played by their associated ciliary proteins in the manifestation of disease phenotype.

Polycystic kidney disease {#Sec18}
-------------------------

Polycystic kidney disease (PKD) is a group of monogenic disorders that are characterised by the presence of multiple cysts, primarily in the kidney and liver and can present both in the neonatal period as well as in adulthood \[[@CR91]\]. PKD is inherited in an autosomal dominant (ADPKD) or recessive (ARPKD) fashion. Typically, ADPKD is diagnosed in the second and third decades of life, while ARPKD presents in utero or in the neonatal period with bilateral enlarged kidneys. ADPKD is one of the most common genetic causes of chronic kidney disease, with an incidence of 1:400--1:1,000, while ARPKD is rare, with an incidence of 1 in 20,000. Macroscopically, ADPKD is characterised by the presence of bilateral grossly enlarged kidneys, which result from the presence of focal cysts occurring at all levels of the nephron. Histologically, ARPKD has a characteristic radial pattern of fusiform cysts present in the dilated collecting ducts. Clinically, patients with enlarged kidney cysts can present with flank pain, haematuria, renal colic, urinary tract infection and hypertension. Cysts may be found in other organs such as the liver, pancreas and seminal vesicles. Rupture of intracranial arterial aneurysms is a significant cause of morbidity and mortality in patients with ADPKD. Childhood-onset end-stage kidney disease is characteristic of ARPKD, with up to 30% requiring renal replacement therapy. ARPKD is suspected when in addition to the renal phenotype, congenital fibrocystic disease of the liver is a manifestation with complications that include portal hypertension, bleeding oesophageal varices and cholangitis.

Autosomal dominant polycystic kidney disease is caused by a mutation in either of two genes,*PKD1* or*PKD2*, encoding polycystin-1 (PC-1) and polycystin-2 (PC-2) respectively. More than 85% of patients have mutations in*PKD1*, while the remaining 15% have mutations in*PKD2* \[[@CR92], [@CR93]\]. PC-1 and PC-2, the encoded polycystin protein products of*PKD1* and*PKD2* respectively form a complex that is located at various cellular sites, which include cell--cell and cell--matrix interactions, the endoplasmic reticulum, in addition to the cilium and/or its basal body \[[@CR94]\]. Fibrocystin is the protein encoded by*PKHD1* (polycystic kidney and hepatic disease 1), the gene mutated in ARPKD and has been found to be associated with the polycystin complex. Fibrocystin also localises to primary cilia and basal bodies \[[@CR95]\].

Homozygous *Pkd1* null mice die between 12.5 and 16.5 days postcoitum and phenotypically exhibit gross cystic appearance of the kidneys and pancreas \[[@CR96]\]. Conditional inactivation of *Pkd1* later than postnatal day 13 results in a much milder course \[[@CR97]\]. Although PKD1 and PKD2 mutations are typically autosomal dominant, somatic second hit mutations, where loss of the second PKD1 or PKD2 allele in the tubular epithelium occurs, have been proposed as a mechanism for focal cyst development in mature ADPKD kidneys \[[@CR98], [@CR99]\]. Recently, co-inheritance of a truncating mutation in one PKD1 allele in trans with missense mutations in a second PKD1 allele has been shown in cases of PKD with onset in utero, in three pedigrees with otherwise typical ADPKD, suggesting a gene dosage effect in PKD \[[@CR17]\]. Rodent *Pkhd1* knockout models develop biliary dysgenesis and fibrosis similar to human ARPKD, while kidney disease is generally mild and of later onset \[[@CR100]\].

Nephronophthisis {#Sec19}
----------------

Nephronophthisis (NPHP) is the most common genetic cause of chronic kidney disease within the first three decades of life \[[@CR101]\]. The prevalence in a population of childhood end-stage renal failure is estimated at 5%. Patients usually present with symptoms of polyuria and polydipsia, secondary enuresis and anaemia. Presentation may occur during infancy, but more typically in late childhood with progressive renal failure manifesting during early puberty. Ultrasound features demonstrate normal sized kidneys with loss of cortico-medullary differentiation and increased echogenicity. Histologically, NPHP kidneys are characterised by the presence of cortico-medullary cysts, tubular basement membrane disruption and tubulointerstitial nephropathy (Fig. [4](#Fig4){ref-type="fig"}b). Extra-renal involvement has been described in over 10% of cases and primarily involves retinal disease, fibrocystic liver disease, cerebellar vermis hypoplasia and skeletal dysplasia.

Inherited in an autosomal recessive mode, NPHP is genetically heterogeneous, with 13 genes currently implicated, (*NPHP1*--*NPHP11*,*NPHP1L*,*SDCCAG8*), which account for only 30% of cases (Supplementary Tables [1](#MOESM1){ref-type=""}, [2](#MOESM2){ref-type=""}). In the remaining 70% of cases, the causative gene is unknown. Recent studies have employed combined homozygosity mapping with "ciliopathy candidate exome capture" followed by massively parallel sequencing to identify*SDCCAG8* as a cause of NPHP \[[@CR76]\]. While mutations in a single gene are sufficient to cause NPHP, it has also been shown that more than one gene can be mutated in patients with NPHP \[[@CR102]\]. Furthermore, truncating mutations can result in a more severe developmental phenotype such as renal dysplasia in Meckel--Gruber syndrome patients with NPHP3 mutations \[[@CR103]\]. A milder phenotype has also been observed for patients with cerebello-oculo-renal syndromes (CORS) syndrome who have missense mutations in RPGRIP1L compared with patients with Meckel--Gruber syndrome who have truncating mutations in the same gene \[[@CR23], [@CR104]\].

Similar to the polycystic kidney disease genes, the nephrocystins have all been localised to primary cilia, basal bodies and centrosomes (Supplementary Table [2](#MOESM2){ref-type=""}). Several NPHP gene products have been shown to interact with each other in addition to other ciliary proteins such as BBS proteins and Ofd1 proteins. Furthermore, subcellular localisation other than primary cilia has been described for several NPHP gene products and includes adherens junctions and focal adhesions (nephrocystin-1 and -4), while nephrocystin-2 localises to different subcellular locations in a cell-cycle-dependent manner where it can be found at the mitotic spindle during mitosis, at the mid-body in cytokinesis while in interphase it can be found in cilia at the basal body and centrosome \[[@CR101]\]. Genetic inactivation in several murine Nphp genes have yielded a range of phenotypes, which include cystic kidneys in both *Inv*^*−/−*^ mice and *Nphp3*^*pcy/ko*^ mice \[[@CR103], [@CR105]\]. Of interest, *Glis2* mutant mice show tubular atrophy and progressive renal fibrosis \[[@CR106]\]. For a comprehensive review of nephronophthisis, the reader is referred to a recent excellent review on this topic elsewhere in this series \[[@CR101]\].

Renal dysplasia {#Sec20}
---------------

While cystic renal disease has historically been described as a cardinal feature of a ciliopathic disorder, other renal malformations such as dysplastic kidneys are often an under-recognised feature. Renal dysplasia occurs as a result of defective differentiation of the renal parenchyma during kidney development \[[@CR107]\]. Histologically, dysplastic features may include incompletely branched collecting ducts surrounded by undifferentiated mesenchymal stroma. Ultrasonographically, dysplastic kidneys may be small (less than the 50th centile for age), unilateral or bilateral, lack cortico-medullary differentiation and demonstrate increased echogenicity with a variable number of small, subcapsular cysts. The degree of renal impairment will depend on the presence of functional nephron mass in the dysplastic kidney and as a result, an elevated creatinine for age may be observed at birth or later during childhood. Other features have included aplastic and hypoplastic kidneys (reduced nephron number and small size) or multicystic dysplastic kidneys characterised by large cysts and no functioning renal parenchyma. Renal dysplasia has been observed in several ciliopathic disorders, which include BBS and Meckel--Gruber syndrome \[[@CR108]\]. As renal dysplasia is essentially a developmental phenotype, its presence in the context of a ciliopathy likely reflects a more severe genotype.

Cystic kidneys and the link to cilia {#Sec21}
====================================

A role for the primary cilium in cystic disease was suggested following the observation that almost all proteins implicated in cystogenesis are localised to the primary cilium. Evidence that cilia are important in cystic kidney disease comes from the initial observation of renal cysts in the Oak Ridge Polycystic Kidney (orpk) mouse that mimic ARPKD. Orpk mice are hypomorphic for*polaris* (also known as*Tg737*), which encodes the mouse orthologue of*Chlamydomonas Ift88*. Cilia in *Tg737orpk* animals are structurally defective and shorter than normal cilia while complete *Tg737* nulls lack cilia and present with neural tube defects, left--right asymmetry and growth arrest during embryogenesis \[[@CR109]\]. Several other mouse models link cilia to cystic kidney disease \[[@CR110]\]. For example, kidney-specific inactivation of *Kif3a* in mice results in a renal epithelium that is devoid of cilia in cystic regions, which appear at 5 days of age \[[@CR12]\]. Furthermore, congenital polycystic kidneys (cpk) are observed in the *cpk* mouse, which carries a mutation in cystin, which localises to the cilium of renal epithelia \[[@CR110]\].

Effector pathways implicated in renal cystogenesis {#Sec22}
==================================================

While a role for cilia in cystogenesis has been proposed, the underlying mechanisms are poorly defined. Previous studies have shown a role for cilia in mediating the switch between canonical and non-canonical Wnt signalling \[[@CR18]\]. Renal cilia project into the tubular lumen and bend in response to tubular flow. Inversin, the protein product of the gene mutated in NPHP type 2 is localised to the primary cilium and mediates a switch from canonical to non-canonical Wnt signalling, which mediates planar cell polarity (PCP). PCP describes the organisation of cells in the plane of an epithelium. Recent studies have provided further support that loss of PCP signalling can lead to renal cystogenesis. Genetic inactivation of *Fat4*, a protocadherin and core PCP effector that is localised to the primary cilium leads to renal cyst formation in mice and is evident at embryonic day 16.5 \[[@CR111]\]. PCP signalling plays a major role in orientating the mitotic spindle along the longitudinal axis of the developing tubule such that over 95% of cells divide within 34° of the axis of the tubule, a process known as orientated cell division (OCD). Defective OCD has been described in the *pck* rat, (*pck* is orthologous to *Pkhd1*) and in *Hnf1ß* mice prior to the development of renal cysts \[[@CR112]\]. However, recent studies in precystic mouse models of *Pkhd1*, *Pkd1* and *Pkd2* failed to identify defective OCD prior to onset of cystogenesis. Loss of OCD was observed, however, during early tubular dilation in both *Pkd1* and *Pkd2* mouse mutants \[[@CR113]\]. Regulation of OCD along the proximo-distal axis during tubular elongation after birth has recently been shown to be regulated by *Wnt9b* signalling \[[@CR114]\]. Furthermore, convergent extension (CE) movements, also regulated by Wnt9b, decrease the number of tubular epithelial cells during tubular morphogenesis until a final tubule diameter is reached. Hypomorphic *Wnt9b* mutant mice develop renal cysts and exhibit defects in OCD and CE.

Other than PCP, several other signalling pathways have been implicated in renal cystogenesis \[[@CR115]\]. In the absence of PCP, canonical Wnt signalling prevails. Over-expression of β-catenin in transgenic mice leads to renal cysts supporting a role for canonical Wnt activation in cystogenesis \[[@CR116]\]. Aberrant Shh signalling has also been associated with renal disease. Mutations in*NPHP7* (*GLIS2*), an intracellular Shh effector, have been described in a subset of patients with nephronophthisis \[[@CR117]\].

Activation of the mTOR pathway has been demonstrated in polycystic kidney disease and several studies have been undertaken to assess a role for mTOR inhibition in polycystic kidney disease \[[@CR118]\]. Altered intracellular calcium homeostasis has been implicated in PKD. Previous studies have shown that calcium influx occurs via the polycystin ion channel complex composed of PC1 and PC2 during tubular flow and is associated with bending of the primary cilium. Furthermore, increased intracellular cAMP has been demonstrated in several PKD animal models. As a result, vasopressin receptor antagonists have been introduced into human clinical trials in ADPKD patients \[[@CR119]\]. As several pathways are implicated in cell proliferation and differentiation, it is likely that many other mechanisms are implicated in renal cystogenesis.

Liver disease and cholangiocyte ciliary dysfunction {#Sec23}
===================================================

Congenital fibrocystic diseases (CFD) of the liver are a heterogeneous group of disorders that are characterised by a spectrum of biliary dysgenesis that includes congenital hepatic fibrosis, bile duct dilatation and cyst formation. Hepatic cysts are lined by cholangiocytes, which are specialised biliary epithelial cells. The concept of cholangiociliopathies first evolved with the observation that patients with CFD frequently have other systemic features including renal disease \[[@CR120]\]. Ciliary dysfunction has been shown to underlie the pathogenesis of both these cystic disorders following the identification and localisation of fibrocystin and nephrocystins, the genes mutated in ARPKD and in NPHP respectively, to the primary cilium of cholangiocytes and renal tubular epithelial cells \[[@CR94], [@CR121], [@CR122]\]. Cholangiocyte cilia regulate bile formation through mechanosensory, osmosensory and chemosensory cues. Defects in cholangiocyte ciliary structure and/or their integrated transducing function lead to a decrease in intracellular calcium and increased cAMP, causing cholangiocyte hyperproliferation, abnormal cell matrix interactions and altered fluid secretion/absorption, which can result in hepatic cystogenesis \[[@CR123]\].

Besides the association with cystic kidneys, CFD also occurs as part of the pleiotropic phenotypes of JBTS/COACH syndrome \[[@CR124]\], BBS \[[@CR125]\], Alström syndrome, Meckel--Gruber syndrome and JATD \[[@CR120]\].

Ciliary dysfunction and retinal disease {#Sec24}
=======================================

Degeneration of the retinal photoreceptors is a common feature of ciliopathic disorders and manifests as progressive loss of peripheral vision. Fundoscopic appearances include maculopathy associated with optic disc pallor, pigmentary changes within the peripheral retina and bone spicule formation (Fig. [4](#Fig4){ref-type="fig"}c). Several proteins implicated in human ciliopathic diseases have been localised to the photoreceptor cilium. Morphologically, photoreceptors have an outer and an inner segment, which are connected by a modified cilium, called the connecting cilium \[[@CR126]\]. Maintenance of photoreceptor integrity relies on continuous IFT. Arrestin, transducin and opsin molecules are synthesised within the inner segment and are then transported via IFT in a light-dependent manner along the ciliary axoneme of the connecting cilium to the outer segment \[[@CR127]\]. Here, phototransduction takes place across an extensive array of photosensitive membranes, which are covered in opsin molecules. About 2,000 rhodopsin molecules per minute are transported to the outer segment via the connecting cilium to compensate for lost material each day when at least 10% of the distal ends of the photoreceptor outer segments are shed and phagocytosed by the surrounding retinal pigmentary epithelium.

A range of photoreceptor abnormalities has been described in several murine ciliopathy models and include the absence of outer segments, disorganised outer segments or photoreceptor degeneration without any obvious abnormalities in photoreceptor morphology. Retinal degeneration has been associated with increased cell death in murine models of *Bbs* \[[@CR128]\]. While the underlying mechanisms of photoreceptor degeneration are largely still unknown, defects in vesicular transport, proteosomal-mediated degradation and IFT have been postulated as potential mechanisms \[[@CR129], [@CR130]\]. Future studies will need to address the specific molecular pathways that become dysregulated in ciliopathic retinal degeneration.

Conclusion {#Sec25}
==========

Since the seminal discovery of BBS8, as a novel ciliary protein, by Ansley and colleagues \[[@CR1]\], the primary cilium has been the focus of intense research across a broad range of scientific disciplines over the past few years. With over 1,000 polypeptides identified within the ciliary proteome, it is highly likely that mutations in several more ciliary genes will be identified in patients presenting with a "ciliopathic" phenotype. While identification of new genes and new ciliary proteins are of fundamental biological interest, it is perhaps even more important to understand the mechanisms underlying the functional consequences of ciliary dysfunction in an organ-specifc context. With the recent development of inducible transgenic models, further investigation in both a spatial and temporal manner within individual organ systems should greatly aid our understanding of the functional consequences of ciliary dysfunction.
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Multiple choice questions (answers appear following the references) {#Sec26}
===================================================================

Characteristic clinical features of a "Ciliopathy" DO NOT include: Renal diseaseRetinal diseaseCerebral malformationsAbdominal distensionCiliopathic syndromes DO NOT include: Joubert syndromeBardet--Biedl syndromeOrofaciodigital syndromeAtypical haemolytic uraemic syndromeWhat is the most common genetic cause of NPHP: NPHP1NPHP4SDCCAG8NPHP5XNPEP3A molecular diagnosis can be made in what percentage of cases of NPHP 25%40%60%10%70%

**Answers**

1\. d

2\. d

3\. a

4\. a
